PropertyValue
?:abstract
  • COVID-19 has now spread globally, and 10–20% of the cases are thought to proceed to a severe condition. However, information on COVID-19 in immunodeficient patients remains limited. We treated a 56-year-old man who developed COVID-19 after chemotherapy for mantle cell lymphoma. After 1 month of prolonged fever, the patient’s respiratory condition deteriorated rapidly, and he died. COVID-19 in immunocompromised patients after chemotherapy, even with mild symptoms, can cause rapid immune reconstitution and respiratory deterioration. Therefore, caution is advised until negative PCR test results for SARS-CoV-2 are confirmed.
?:creator
?:doi
  • 10.4269/ajtmh.20-0678
?:doi
?:journal
  • Am_J_Trop_Med_Hyg
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/367985e5c6f7b12c634a6cdd260a016bb96d32e6.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7646807.xml.json
?:pmcid
?:pmid
?:pmid
  • 32940203.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Case Report: A Patient with COVID-19 under Myelosuppression Induced by Chemotherapy
?:type
?:year
  • 2020-09-16

Metadata

Anon_0  
expand all